U.S. federal trademark · Serial No. 97029671
Stem cell therapy services; Immunotherapy services in the nature of medical services; collection and preservation of biological tissue, blood and cells; Medical diagnostic testing, monitoring, and reporting services; Medical treatment of of cancer such as colon carcinoma, lymphoid malignancy, pancreatic cancer, breast cancer, lung cancers, ovarian cancer, prostate cancer, and autoimmune diseases such as Systemic lupus erythematosus (SLE); Health care services, namely, providing a database in the field of cell therapy such as Chimeric Antigen Receptor therapy, TCR (T-Cell Receptor) therapy, TIL (tumor-infiltrating lymphocyte) therapy, Natural Killer (NK) cell therapy, and Stem Cell therapy, and gene therapy information and featuring inputting and collection of data and information all for treatment and diagnostic purposes; providing medical information; services in the extraction of cells from patients in the nature of stem cell therapy services; manipulation of cells for therapeutic purposes in the nature of stem cell therapy services; reinsertion of cells into human patients in the nature of stem cell therapy services
Scientific research in the nature of conducting clinical trials for others in the field of pharmaceutical preparations and drugs in the field of immunotherapy; Scientific research in the nature of conducting clinical trials for others in the field of pharmaceutical preparations and drugs in the field cell therapy
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.